G. Fuertes et al., Changes in hypothalamic paraventricular nucleus catecholaminergic activityafter acute and chronic morphine administration, EUR J PHARM, 388(1), 2000, pp. 49-56
The participation of hypothalamic noradrenaline in the expression of neuroe
ndocrine signs of morphine withdrawal has been proposed. The present study
in rats examined: (1) the relationships between corticosterone secretion an
d the possible modifications in noradrenaline and dopamine content and turn
over in the hypothalamic paraventricular nucleus after acute and chronic mo
rphine administration; (2) the changes in cyclic adenosine monophosphate (c
AMP) levels in the paraventricular nucleus after the same treatments. The r
esults showed that acute morphine injection in control rats increased corti
costerone release, 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) producti
on, and noradrenaline turnover. Dopamine turnover in the paraventricular nu
cleus was decreased and the cAMP levels remained unchanged. In chronic morp
hine-treated rats, there was no elevation in noradrenaline turnover or in c
orticosterone secretion, indicating that tolerance developed to the acute e
ffects of the opioid. Correspondingly, no alterations in dopamine turnover
were observed when chronic morphine-treated rats were compared with control
rats acutely injected with morphine. cAMP levels in the paraventricular nu
cleus were unchanged during the tolerant state. The results raise the possi
bility that noradrenergic afferents play a significant role in the alterati
ons of paraventricular nucleus function and pituitary-adrenal axis activity
in response to acute and chronic morphine and suggest that these modificat
ions are not mediated through adenylate cyclase activation. The present dat
a provide further support for the idea of adaptive changes in noradrenergic
neurons projecting to the paraventricular nucleus during chronic morphine
exposure. (C) 2000 Elsevier Science B.V. All rights reserved.